EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drug-Loaded Mesoporous Silica Nanoparticles Enhance Antitumor Immunotherapy by Regulating MDSCs

Changlin Xu, Nida Amna, Yuchen Shi, Rong Sun, Chenhui Weng, Jiaoyu Chen, Huaxing Dai, Chao Wang iD

Molecules · 2024

DOI: 10.3390/molecules29112436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Changlin Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Function Materials and Devices, Soochow University, S…. Hauptthemen laut MEDLINE: Silicon Dioxide, Nanoparticles, Myeloid-Derived Suppressor Cells, Immunotherapy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suzhou Key Laboratory of Nanotechnology and Biomedicine, Collaborative Innovation Center of Suzhou Nano Science & Technology, 111 Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myeloid-derived suppressor cells (MDSCs) are recognized as major immune suppressor cells in the tumor microenvironment that may inhibit immune checkpoint blockade (ICB) therapy. Here, we developed a Stattic-loaded mesoporous silica nanoparticle (PEG-MSN-Stattic) delivery system to tumor sites to reduce the number of MDSCs in tumors. This approach is able to significantly deplete intratumoral MSDCs and thereby increase the infiltration of T lymphocytes in tumors to enhance ICB therapy. Our approach may provide a drug delivery strategy for regulating the tumor microenvironment and enhancing cancer immunotherapy efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Silicon DioxideNanoparticlesMyeloid-Derived Suppressor CellsImmunotherapyTumor MicroenvironmentAnimalsMicePorosityHumansNeoplasmsCell Line, TumorDrug CarriersDrug Delivery SystemsPolyethylene Glycols

Stichwörter der Autor:innen

ICB therapyPEG-MSNmyeloid-derived suppressor cellsstattictumor therapy

Substanzen

Silicon DioxideDrug CarriersPolyethylene Glycols

Autor:innen und Institutionen

  • Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Function Materials and Devices, Soochow University, Suzhou 215123, China.

ORCID-Profile: Chao Wang

Förderung

  • Suzhou Key Laboratory of Nanotechnology and Biomedicine
  • Collaborative Innovation Center of Suzhou Nano Science & Technology
  • 111 Project
  • Joint International Research Laboratory of Carbon-Based Functional Materials and Devices

Zitieren

APA

Xu, C., Amna, N., Shi, Y., Sun, R., Weng, C., Chen, J., Dai, H., & Wang, C. (2024). Drug-Loaded Mesoporous Silica Nanoparticles Enhance Antitumor Immunotherapy by Regulating MDSCs. Molecules. https://doi.org/10.3390/molecules29112436

Vancouver

Xu C, Amna N, Shi Y, Sun R, Weng C, Chen J, et al. Drug-Loaded Mesoporous Silica Nanoparticles Enhance Antitumor Immunotherapy by Regulating MDSCs. Molecules. 2024. doi:10.3390/molecules29112436

BibTeX
@article{Xu2024,
  author = {Xu, Changlin and Amna, Nida and Shi, Yuchen and Sun, Rong and Weng, Chenhui and Chen, Jiaoyu and Dai, Huaxing and Wang, Chao},
  title = {Drug-Loaded Mesoporous Silica Nanoparticles Enhance Antitumor Immunotherapy by Regulating MDSCs},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29112436}
}
Kostenlos starten →